Evolutionary Tree Capital Management, LLC — 13F Portfolio

Evolutionary Tree Capital Management, LLC is a U.S.-based investment management firm registered with the U.S. Securities and Exchange Commission as an investment adviser. The firm appears in regulatory filings as an institutional investment manager and reports U.S.-listed holdings on Form 13F under CIK #0001844345. Evolutionary Tree Capital Management operates as a specialist equity manager, with its advisory activity focused on innovation-driven companies and secular growth themes. Client capital is typically managed in separately managed accounts and/or pooled vehicles following the same underlying research and portfolio-construction discipline. Form 13F filings aggregate the long U.S. equity and equity-like positions held across these accounts into a single quarterly report, providing an outside view of the firm’s listed holdings implementation. The firm’s 13F History, beginning in the early 2020s, shows a pattern consistent with a concentrated, active growth manager: a focused list of individual equities, predominantly in innovation-heavy sectors, with limited use of broad index ETFs. Within an institutional analytics environment, these filings are linked into a continuous 13F Portfolio Composition time series, while the original SEC reports remain the definitive source for position-level disclosure.

Evolutionary Tree Capital Management pursues a fundamentally driven, long-only growth equity strategy with a strong emphasis on innovation and structural change. The investment philosophy centers on the idea that economic progress unfolds along "evolutionary trees" of innovation—technologies, platforms, and business models that branch into new products and services over time. The firm seeks to identify companies positioned on attractive branches of these trees, where innovation can support durable revenue and cash-flow growth. Security selection is bottom-up and research-intensive. Analysts focus on competitive advantage, addressable market, innovation pipelines, unit economics, and management’s ability to allocate capital effectively. The approach emphasizes quality growth—businesses with robust balance sheets, recurring or highly visible revenue streams, and strong competitive moats—rather than speculative, binary-outcome situations. Sector exposures in the 13F filings tend to cluster in technology, communication services, healthcare, and innovation-linked consumer and industrial franchises. However, sector weights are the byproduct of stock selection rather than top-down mandates. Portfolios are deliberately concentrated, with a core group of high-conviction positions representing a significant share of total exposure, complemented by smaller satellite holdings that may be earlier-stage ideas or risk-managed positions. Turnover inferred from quarter-to-quarter holdings changes is generally low to moderate. Positions often remain in the portfolio for multiple years as long as the underlying thesis is intact and valuations stay within the firm’s assessment of fair value. Trading activity tends to reflect thesis upgrades/downgrades, relative valuation shifts, or fundamental inflection points rather than frequent tactical timing. Within a 13F-based Portfolio Simulator or Backtesting Service, Evolutionary Tree’s disclosed holdings can be converted into an approximate Historical Track Record. By applying market data to each quarter’s 13F snapshot and normalizing to a user-defined notional, allocators can study how a notional portfolio mirroring the firm’s U.S.-listed long book would have behaved across growth-led rallies, factor rotations, and risk-off episodes, subject to the usual constraints of 13F-based historical replication.

Viewed through its public filings under CIK #0001844345, Evolutionary Tree Capital Management, LLC presents as a research-driven, innovation-focused growth equity manager running concentrated, high-conviction portfolios in structurally growing sectors. Its 13F History reflects a focused roster of quality growth companies, low to moderate turnover, and a sector mix dominated by technology, communication services, healthcare, and other beneficiaries of long-term innovation trends. For allocators leveraging a 13F analytics platform, the firm’s filings enable a detailed review of how its 13F Portfolio Composition has evolved through different market regimes—whether the portfolio has maintained consistent exposure to core innovation themes, how concentration in top holdings has changed, and how sector tilts have adjusted in response to macro and competitive shifts. By feeding this holdings history into a Backtesting Service or Portfolio Simulator, users can generate a proxy Historical Track Record and evaluate volatility, Max Drawdown Depth, and Sharpe Ratio for a notional portfolio aligned with the manager’s disclosed long book. Because 13F-based analysis captures only reportable long U.S.-listed positions and does so at quarterly intervals, it should be interpreted as a partial view of the firm’s activity and client experience. An open question for further due diligence is how Evolutionary Tree Capital Management’s innovation-centric process and portfolio construction framework respond to sustained shifts in regime—such as prolonged periods of higher interest rates, changing regulatory stances on dominant technology platforms, or extended value-led markets—and how that adaptability (or intentional persistence) shapes future risk-adjusted outcomes.

The risk profile implied by Evolutionary Tree Capital Management’s 13F disclosures is characteristic of a concentrated, innovation-focused growth equity strategy. Key risk dimensions include: - Sector and thematic concentration: A structural tilt toward technology, communication services, and healthcare exposes the portfolio to shifts in sentiment toward long-duration growth assets, regulatory changes, and technological disruption cycles. - Factor exposure: Emphasis on quality growth and innovation typically results in meaningful exposure to growth and quality factors, and a relative underweight to deep value or highly cyclical segments of the market. Periods of growth-to-value rotation can therefore be challenging. - Idiosyncratic risk: Concentrated position sizes in high-conviction names mean that company-specific developments—product cycles, competitive dynamics, regulatory rulings, or execution missteps—can materially influence the capital trajectory. The strategy is long-only in the 13F context, and thus participates in broader equity drawdowns. The depth and pattern of drawdowns are shaped by the interaction between growth factor performance and overall market stress. Innovation-led equities can experience sharper drawdowns in environments of rising real interest rates, valuation compression, or risk aversion toward unprofitable or early-stage business models, even if the portfolio’s quality bias provides some protection relative to more speculative peers. Using 13F data as inputs, allocators can reconstruct indicative portfolios and estimate volatility characteristics and downside behavior across observable stress episodes. Metrics such as Max Drawdown Depth and a reconstructed volatility profile provide insight into the amplitude of cyclicality, while risk-adjusted outcome measures like Sharpe Ratio—derived from backtests of the long-only proxy—help frame the trade-off between upside participation in innovation cycles and exposure to style- and sector-driven setbacks.